Dosimetric Comparison of Cesium-131 and Palladium-103 for Permanent Prostate Brachytherapy

Cancer types prostate


J.S. Musmacher, R.T. Byrnes, M. Ghaly, K. Satchwill, L. Rumpf

International Journal of Radiation Oncology Biology Physics
November 1, 2007

Related posts

Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point

Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi, L. Minsky, N. Kahan, W. Bodner, M. Garg, S. Kalnicki, C. Guha

Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution

Authors: C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel

Scroll to top